PTC Therapeutics Inc

PTCT

Market Cap$2.61B

Close$

Compare PTC Therapeutics

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
PTC Therapeutics Inc	-4.5	0%	65%	2.8	-0.3
Market Avg	53.2	1.27%	29%	-	1.3
Healthcare Avg	29.7	1.32%	16%	7.3	1.3

$30.00

Target Price by Analysts

9.3% downsidePTC Therapeutics Target Price Details

$29.89

Current Fair Value

9.7% downside

Overvalued by 9.7% based on the discounted cash flow analysis.

Share Statistics

Market cap	$2.61 Billion
Enterprise Value	$2.03 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-7.67
Beta	1.43
Outstanding Shares	76,696,785
Avg 30 Day Volume	1,010,715

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-4.51
PEG	13.21
Price to Sales	2.76
Price to Book Ratio	-2.76
Enterprise Value to Revenue	2.19
Enterprise Value to EBIT	-7.25
Enterprise Value to Net Income	-4
Total Debt to Enterprise	0.15
Debt to Equity	-0.34

Revenue Sources

No data

ESG Score

No data

About PTC Therapeutics Inc

CEO: Stuart Peltz